YUMAB GmbH
PrivateLast Round
Grant
Jan 27, 2025
Company Overview
YUMAB GmbH is a biotechnology company that provides contract research, technologies, and R&D services for the development of fully human therapeutic antibodies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
YUMAB GmbH Comparables
Compare YUMAB GmbH with similar companies based on industry and business-model similarity.
YUMAB GmbH Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jan 27, 2025 | ||||
| Grant | Oct 17, 2023 | ||||
| Grant | Jul 19, 2023 |
YUMAB GmbH Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Bundesministerium für Bildung und Forschung | Grant |
| NBank | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 3, 2025
Monthly visitors grew 308% MoM, reaching 4.9K.
- Jan 27, 2025
Secured $1M in grant funding from NBank.
YUMAB GmbH Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about YUMAB GmbH's valuation, stock price, and market status.